MedTrace Logo

Celsius TCS Hyperthermia System PMCF Trial

NCT02896049 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-07-27

No results posted yet for this study

Summary

Based on the basic data of all patients foreseen for a local hyperthermia in the participating centers the failure rate (of the Celsius TCS Hyperthermia System) and the complication rate (injury to the patients) will be recorded.

Conditions

  • Solid Neoplasms

Interventions

DEVICE

Hyperthermia

treatment with the Celsius42 Hyperthermia System additional to radiotherapy and/or chemotherapy

Sponsors & Collaborators

  • Aix Scientifics

    collaborator INDUSTRY

  • Celsius42 GmbH

    lead INDUSTRY

Principal Investigators

  • Hüseyin Şahinbaş, MD · Praxis-Klinik Hyperthermie

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-11-30
Completion
2017-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02896049 on ClinicalTrials.gov